reserving the right to object, Americans deserve a transparent, affordable, and accessible prescription drug market. I agree with the concerns that each of my colleagues have raised here tonight. The current system fails to meet these needs, and I appreciate the intentions of my colleagues in attempting to shed light on the opaque pricing system that we now face. The problem is that the solution proposed in Senate bill 1250 is the wrong solution. If you listened carefully to the debate of my colleagues, their main objection was that the prescription drug companies are advertising and promoting and creating markets for their products. Their solution is to have them tell you what the price is, and what they are asking in their legislation is that the prescription drug manufacturers be required to state their list price. But we all know that the list price is not actually the correct price, and it will actually create confusion even further by forcing these pricing numbers to be put out into the marketplace through commercial advertising in a way that will then, I believe, undercut the major reforms that we are now undertaking in the Finance Committee to get the opaque system eliminated, to shed transparency onto the system, and help all consumers--including the United States Government--to understand what the real price is.…
Share
More from Mike Crapo
Tomorrow, this Chamber will have the opportunity to chart a new path forward on healthcare in this country. Senators will be given the choice to extend the Biden COVID bonuses for another 3 years or to support healthcare reforms that will…
the Senate has important work to accomplish today to prevent a more than $4 trillion tax hike on American workers and families, and we will accomplish that goal. However, while business continues here, life for the North Idaho community of…
There is no debate that Jeffrey Epstein's crimes of sexual abuses and other crimes are appalling. And the investigation there is, ongoing, must focus on bringing those who participated to justice. The Justice Department already has been…
The fact is that I completely agree with the objective of my colleagues on the floor today that we need to get transparency in the prescription drug pricing system. Americans deserve a transparent, affordable, and accessible prescription…





